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NMR Spectroscopy
Alexandra M. Olaru,[a] Thomas B. R. Robertson,[b] Jennifer S. Lewis,[a] Alex Antony,[b]
Wissam Iali,[a] Ryan E. Mewis,*[b] and Simon B. Duckett*[a]
1. Introduction
Hyperpolarized magnetic resonance spectroscopy (MRS) meth-
ods have been successfully used in conjunction with 1H, 13C,
and 15N detection.[1] An important nucleus that could success-
fully be exploited in a similar manner is 19F. Its detection has al-
ready been shown to give remarkable results in traditional (i.e.
thermal equilibrium) MRS applications.[2] Furthermore, 18F
radio-labelled positron emission tomography (PET) agents are
highly successful in the clinic as diagnostic probes.[3]
In the context of MRS applications, 19F presents several sig-
nificant advantages over 13C and 15N detection, as it is spin-1=2,
100% abundant, and has 83% of the sensitivity of 1H detec-
tion. Moreover, it has a very wide and, hence, diagnostic chem-
ical shift range (much larger than those of 13C and 31P and
comparable to that of 15N) and it is not present endogenously
in biological tissue, so there is no competing background
signal to obscure the corresponding in vivo data. The large
chemical shift range exhibited by hyperpolarized 129Xe nuclei
reflects one of the reasons this alternative probe is attracting
so much attention. So far, 19F MRS has been used to aid the
probing of catabolic and anabolic drug conversions of anti-
cancer agents such as 5-fluorouracil[2, 4] and the uptake and
elimination of modern anesthetics used in preclinical magnetic
resonance imaging (MRI).[5] It has also been used for the nonin-
vasive pharmacokinetic analysis of Voriconazole in the brain
and plasma.[6] Its large chemical shift range and high sensitivity
to the local environment have been exploited in the assess-
ment of cellular metal-ion concentrations,[7] tissue oxygena-
tion,[8] and pH.[9]
Various approaches to improve the typically low signal-to-
noise ratio (SNR) of 19F MRI experiments are presented in the
literature, such as increasing the number of 19F atoms per mol-
ecule. Variations in transverse relaxation times have also been
exploited to provide molecular environment data.[10] Hyperpo-
larization has been shown to be a very promising way of ob-
taining significantly stronger 19F signal compared to conven-
tional methods. So far, the 19F nuclear magnetic resonance
(NMR) response of various compounds has been successfully
enhanced using both dynamic nuclear polarization[11] and PHIP
(para-hydrogen-induced polarization).[12] The hyperpolarization
of the 19F nucleus of 3-fluoropyridine using signal amplification
by reversible exchange (SABRE), which is also a para-hydrogen
(p-H2)-based technique, was reported in 2009 by Adams
et al.[13] More recently, Shchepin et al.[14] presented the first hy-
perpolarized 19F SABRE MRI results using the same molecule
and achieved signal enhancements of 100-fold at 9.4 T by
using SABRE-SHEATH (shield enables alignment transfer to het-
eronuclei).[15] Furthermore, a very recent report detailed the
use of a superconducting quantum interference device
(SQUID) for the simultaneous measurement of 1H and 19F spec-
tra using SABRE.[16] 3-Fluoropyridine, ethyl-5-fluoronicotinic
Fluorinated ligands have a variety of uses in chemistry and in-
dustry, but it is their medical applications as 18F-labelled posi-
tron emission tomography (PET) tracers where they are most
visible. In this work, we illustrate the potential of using 19F-con-
taining ligands as future magnetic resonance imaging (MRI)
contrast agents and as probes in magnetic resonance spectros-
copy studies by significantly increasing their magnetic reso-
nance detectability through the signal amplification by reversi-
ble exchange (SABRE) hyperpolarization method. We achieve
19F SABRE polarization in a wide range of molecules, including
those essential to medication, and analyze how their steric
bulk, the substrate loading, polarization transfer field, pH, and
rate of ligand exchange impact the efficiency of SABRE. We
conclude by presenting 19F MRI results in phantoms, which
demonstrate that many of these agents show great promise as
future 19F MRI contrast agents for diagnostic investigations.
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acid and 3,5-bis(trifluoromethyl)pyridine were investigated. In
addition, a further report described an attempt to utilize con-
tinuous hyperpolarization to hyperpolarize pentafluropyri-
dine,[17] but it was unsuccessful as the latter did not polarize.
We seek to add to these early studies by screening a wide
range of substrates to increase the applicability of this ap-
proach and suggest optimal routes to increasing 19F hyperpola-
rization by SABRE.
SABRE utilizes p-H2,
[13] which is a spin isomer of H2. As a nu-
clear singlet, it has no net spin and, so, it is unobservable from
an NMR perspective. However, once p-H2 has come into con-
tact with a metal center, thereby forming p-H2-derived hydride
ligands, this previously NMR invisible singlet state can be ac-
cessed. Now, polarization is transferred from the p-H2-derived
nuclei to spin-1=2 nuclei that are located in ligands attached to
the same metal center through the J-coupling network.[18] The
ligands that lie trans to the p-H2-derived hydrides receive po-
larization optimally, as they exhibit the largest difference in cis
and trans couplings. The reversible nature of both H2 addition
and analyte ligation at the metal center enables hyperpolariza-
tion to buildup in non-ligated analyte molecules in a process
that has been described as being catalytic in the transfer of
polarization. The hyperpolarization that is created in this way
can be readily read-out in an NMR experiment and, hence, the
signal intensity of the resulting NMR spectrum or magnetic res-
onance (MR) image is suitably enhanced (Scheme 1).
The transfer of polarization through SABRE typically occurs
at low magnetic field and is maximized when a level anti-cross-
ing (LAC) condition is met.[19] This is associated with the spin
system becoming strongly coupled as a consequence of the
chemical shift difference between the interacting groups col-
lapsing to values that match the shared spin–spin couplings,
thus resulting in coherent polarization transfer. Consequently,
the efficiency of polarization transfer is field dependent. How-
ever, methods exist to transfer such polarization at high mag-
netic field in the presence of radio frequency excitation,[20]
such that hyperpolarized NMR spectra can be collected.[21] Po-
larization transfer through SABRE has, in fact, been shown to
be successfully transferred to 1H,[13,22] 13C,[22a, 23] 15N,[24] 19F,[13,14, 16]
31P,[25] 29Si, and 119Sn.[26]
We further note that there are a large number of drugs that
contain 19F nuclei ; in 2010, it was calculated that about 20% of
administered drugs contained fluorine atoms or fluoroalkyl
groups.[27] In this work, we test a range of 19F-containing sub-
strates and drug molecules with a pyridyl arrangement (as de-
picted in Scheme 2) to demonstrate the possibility of applying
SABRE in MR material and clinical investigations that rely on
the response of 19F nuclei. Furthermore, we seek to determine
the conditions required for maximizing the 19F NMR response
of different ligands.
2. Results and Discussion
2.1. Formation of SABRE Polarization-Transfer Catalysts
Prior to investigating the polarization transfer to the 19F nuclei
of ligands L1–L6 (Scheme 2) using the pre-catalyst [Ir(IMes)-
Scheme 1. SABRE polarization-transfer process: The substrate S and p-H2 form temporary bonds with an iridium-based catalyst. The polarization is transferred
through scalar coupling from the p-H2 to the substrate, which later dissociates. When interrogated through NMR methods, the free polarized substrate gives
rise to enhanced signals.
Scheme 2. Ligands investigated in this work.
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(COD)Cl][28] 1 (COD=cyclooctadiene; IMes=1,3-bis(2,4,6-trime-
thylphenyl)imidazole-2-ylidene), we probed the ability of L1–L6
to displace the chloride ligand of 1 to give [Ir(IMes)(COD)L]+ .
This step has been shown to be important during SABRE acti-
vation and its absence would suggest a substrate that is un-
likely to polarize.[29] Unfortunately, attempts to isolate L3.HCl as
the free base were unsuccessful under the conditions that we
needed to employ the ligand. This is attributed to the fact that
4-fluoropyridine reacts with itself to give N-(4’-pyridyl)-4-fluoro-
pyridinium fluoride, which hydrolyzes to N-(4’-pyridyl)-4-pyri-
done (see Section 2.1 of the Supporting Information).[30] Thus,
this ligand was not investigated in detail. However, L1, L2, L4,
L5, and L6 were successfully employed.
A 256-scan 19F NMR spectrum of 20 equivalents of L1 or L5 in
the presence of 1 (5 mm) yielded only a single set of peaks,
that of free L1 or L5. A second set of peaks, owing to the for-
mation of [Ir(IMes)(COD)L]+ , was not observed. This contrasts
strongly with the data obtained for L2 under the same condi-
tions, in which two peaks are observed in a ratio of 0.84:19.16
that correspond to [Ir(IMes)(COD)L2]+ and free L2, respectively.
These two peaks are separated by 362 Hz in a 1.4 T NMR field.
The same observation was made when L2 was exchanged for
L4 ; in this case, the two peaks were separated by 335 Hz in a
1.4 T NMR field, although the ratio was smaller (0.25:19.75 for
L4/[Ir(IMes)(COD)L4]+). Conversely, when L5 was used, the
19F NMR spectrum comprised of only three peaks, representa-
tive of the three different 19F NMR environments that L5 pos-
sesses. Just like L1, there were no other observable peaks for
bound L5. As both L1 and L5 possess ortho-fluorine nuclei,
there could be a possibility that steric hindrance around the ni-
trogen used to ligate to the metal center of 1 is preventing ef-
fective ligation. Compared to hydrogen, 19F has a greater
van der Waals radius by 0.27 , but is still smaller than a
methyl group (van der Waals radius 2.00 ).[31] Shchepin et al.
reported that lutidines and picolines possessing a methyl
group in the ortho-position yielded no detectable 15N hyper-
polarization through SABRE-SHEATH.[15] In addition, the pKa of
L1 (0.44) is such that it may not be an effective ligand in
comparison to pyridine (pKa=5.23) or 3-fluoropyridine (pKa=
2.97). To the best of our knowledge, no reported pKa data are
available for L4, although 3,5-dichloropyridine has a reported
pKa of 0.51.
[32] L4 would be expected to have a similar pKa and,
thus, is more basic than L1 but less so than L2. Wang et al. indi-
cated that the pKa of L
4 was <2, as the hydrolysis rate of their
ruthenium complexes increased relative to when pyridine or 3-
picoline were employed.[33] L5 is reported to not react with hot
aqueous hydrogen iodide or hydrochloric acid, owing to the
base-weakening effect of the two ortho-fluorines.[34] The com-
bination of steric as well as binding affinity to the metal center
may preclude L1 and L5 acting as efficient ligands to 1. L5 has
previously been reported as not being SABRE active.[17]
2.2. 1H SABRE Hyperpolarization of F-Substituted Ligands
We then sought to evaluate the ability of 1 to form efficient
SABRE polarization-transfer catalysts with the ligands shown in
Scheme 2. This is normally associated with the formation of
[Ir(H)2(IMes)(L)3]Cl. L
1, when examined under SABRE, produced
a small enhancement (below unity) for both ligand loadings
tested here (4 and 20 equivalents of L relative to 1). Further-
more, a strong hydride signal for the corresponding complex
[Ir(H)2(IMes)(L
1)3]Cl was not observed. Attempts to increase the
binding strength by using a smaller carbene (IMe) were unsuc-
cessful (see Section 2.1 of the Supporting Information). Hence,
L1 is poorly suited to SABRE.
In contrast, L2 proved to provide a substantial 1H SABRE re-
sponse. When the substrate loading is 1:4, 1H SABRE NMR
spectra recorded after adding 3 bar of p-H2 and shaking the
sample for 10 s in a field of approximately 65 G show that the
protons H-2 and H-6 of L2 exhibit a 2103-fold summed signal
gain, which compares to an enhancement of 2397 reported
for pyridine by Lloyd et al. under analogous conditions.[29]
When the metal/ligand ratio is 1:20, which corresponds to 17-
fold excess of ligand to catalyst (spectra presented in Figure 1),
the corresponding values are 393-fold for pyridine and 1296-
fold for L2, a value approximately six times higher than the
one reported by Shchepin et al. for the same sample at 9.4 T.[14]
We attribute this significant difference to the difference in the
purity of the p-H2 gas used for sample polarization (96% in
this work and 50% in Ref. [14]). This suggests that L2 is a good
agent for SABRE in accordance with early observations[13,14] and
confirms that the p-H2 concentration has a significant effect on
the efficiency of the polarization transfer process.
1H NMR spectra recorded after H2 addition and subsequent
catalyst activation show that [Ir(IMes)(H2)(L
2)3] is formed and is
the dominant SABRE polarization-transfer catalyst in solution,
with a diagnostic hydride signal at d23.11 ppm. A second
complex, indicated by a pair of hydride resonances d at 23.87
and 25.15 ppm, was found to be [Ir(IMes)(H2)(L2)2(MeOH)]
(see the Supporting Information for further details and charac-
terization data). The possibility of Cl rather than methanol
Figure 1. 1H NMR spectra of L2 (17-fold excess) acquired in thermal equilibri-
um conditions (top, 128 scans) and hyperpolarized under SABRE (bottom,
one scan).
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binding was excluded by acquiring spectra of the same reac-
tion in dichloromethane and comparing the results. As exem-
plified elsewhere,[35] methanol can be an active participant in
the polarization-transfer catalyst and, when employing mild
acidic conditions, solvent polarization can be observed and
quantified by measuring the enhancement of the OH reso-
nance. Although evidence for methanol binding was obtained,
no OH or residual CD2HOD signal enhancement was observed.
Shchepin et al. presented 1H NMR spectra in their Supporting
Information, which possess unattributed signals that may re-
flect the observation of species of this type.[14]
The activation parameters corresponding to the process of
free ligand buildup in solution following dissociation from the
dominant complex were calculated by using data obtained
from a series of variable-temperature exchange spectroscopy
(EXSY) measurements (see Section 2.4 of the Supporting Infor-
mation). The L2 buildup rate at 300 K was extrapolated
through Eyring analysis and was found to be 65.1 s1, that is,
approximately 2.8 times larger than the corresponding rate of
pyridine measured using the same conditions.[29] Furthermore,
the enthalpy value for the buildup process of 98 kJmol1 sug-
gests that the binding energy is slightly higher than that of
pyridine (for which the site trans to hydride has a DH(build-up)
value of 95 kJmol1).
When considering the related molecules L4, L6, and L7, very
good 1H SABRE polarization (of the order of hundreds up to
thousands) was obtained in all cases. The SABRE polarization-
transfer catalysts formed with 1 in solution are the tris-substi-
tuted species, [Ir(IMes)(H)2(L)3]
+ , and the analogous methanol
complex, [Ir(IMes)(H)2(L)2(MeOH)]
+ (see the Supporting Infor-
mation for enhancement values, thermodynamic parameters,
and characterization data).
A series of one-shot 1H NMR spectra were collected on sam-
ples containing one-fold and 17-fold excesses of L7 in the pres-
ence of 5 mm of 1 in MeOD solution. In the case of the sample
containing a one-fold excess, substantial signal enhancements
were observed for all three of the non-exchangeable resonan-
ces of the free substrate, with the largest 1H NMR signal en-
hancement being observed for H-2 (27224), followed by H-
4 and H-6 (18116 and 1219 at 400 MHz, respectively).
The corresponding values for the solution containing a 17-fold
excess of ligand were 592, 502, and 552. These values
are much lower than those seen for L2 and reflect the fact that
the protonated form of the free ligand (L7a) dominates in
solution.
Evidence for methanol binding to the iridium center was
again seen in the hydride region of the associated 1H NMR
spectra, which, in the case of L7, contains a resonance at
d23.45 ppm, corresponding to the tris-substituted complex.
A pair of resonances, located at d23.84 and 24.04 ppm,
arise from a complex where the equatorial sites are occupied
by one substrate molecule, one methanol molecule, and two
hydrides.
The corresponding 1H SABRE NMR experiments now result
in a polarized OH resonance, exhibiting average enhancement
values of 6.650.5 (one-fold excess) and 512 (17-fold
excess). We have shown, in our previous work,[35a] that the de-
protonation of the N center of the conjugate acid form of nico-
tinic acid and, subsequently, more efficient binding to 1, can
be achieved by adding a mild base to the solution. When ana-
lyzing samples containing 20 and 100 mm of L7 after adding
Cs2CO3 in equal amounts to the substrate (one-fold and 17-
fold excess to 1, respectively), the enhancement of the free-
ligand resonances increases considerably in both cases, as a
result of the molecule being deprotonated (L7b) and increas-
ing the ligand’s probability of binding to the catalyst. We note,
however, that in the case of low ligand loading, the presence
of base promotes and accelerates H–D exchange, a phenom-
enon that occurs immediately after activation and on the time-
scale of the experiments, resulting in a progressive decrease of
the total enhancement with each addition of fresh p-H2. Data
shows that at least 40% deuteration of the three sites takes
place in the first 15 minutes (see Section 2.2 of the Supporting
Information).
For the sample prepared using a one-fold excess of ligand
and a one-fold excess of base, relative to the catalyst, the total
signal enhancement obtained across the three sites was 2.5-
times higher than that seen for a similar sample prepared with-
out base; the corresponding difference increased to 4.5 times
for the 17-fold loading (spectra presented in Figure 2). Further-
more, neither methanol binding nor OH signal enhancement
was observed when the base was present. These results relate
to those reported for niacin[35a] and confirm the importance
that the pH can play in manipulating substrate binding.
We have also analyzed the fluorine-substituted nucleobase
used widely used in cancer therapy, 5-fluorouracil (L8, com-
monly sold under the commercial name of Adrucil), and the
anti-fungal drug Vorincazole (L9), both of which are listed on
the World Health Organisation’s essential medicines list. As L8
is present in solution in its fully protonated form (thus prevent-
ing the N centers from binding to 1), we adopted a strategy
similar to the one used for L7 to promote the formation of the
Figure 2. 1H NMR single-shot SABRE hyperpolarized spectra of 5-fluoronico-
tinic acid before (L7a, top) and after (L7b, bottom) addition of Cs2CO3 for a
sample prepared by using a 17-fold excess of ligand to catalyst.
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SABRE polarization-transfer catalyst and to improve the signal
enhancements. In the hydride region of this 1H NMR spectrum,
we initially see two signals at d15.4 and 18.1 ppm, which
are in emission and absorption, respectively, owing to the for-
mation under ALTADENA (adiabatic longitudinal transport after
dissociation engenders nuclear alignment)[36] conditions
(Figure 3). We note that these observations are consistent with
other reports that have considered the activation of SABRE cat-
alysts.[37] In addition, we see two SABRE enhanced CH resonan-
ces belonging to a bound COE (cyclooctene) ligand at d 3.57
and 3.35 ppm, which is consistent with a prior report,[37a] as
well as a weakly polarized peak corresponding to the mesityl
protons of the carbene.
Hence, the initial product, [Ir(H)2(IMes)(COE)(L
8)2]Cl, exhibits
significant SABRE activity. The signal enhancement reduces
over the next 5 minutes, as this complex is converted into mul-
tiple species (see the Supporting Information for detailed infor-
mation). Under these conditions, when the excess of L8 is four-
fold and 0.5-fold excess of Cs2CO3 is present, we see a signal at
d 7.56 ppm, corresponding to the free resonance of H-5. This
signal possesses an initial enhancement of 53-fold and a
second peak at d 5.97 ppm, corresponding to the H-5 reso-
nance of the ligand when bound to the Ir center, shows an ini-
tial 26-fold enhancement. A set of optimization experiments
were undertaken to identify the best base and ligand concen-
trations, and ultimately a 100-fold 1H NMR signal enhancement
was obtained for the free H-5 resonance of L8 and approxi-
mately a 57-fold enhancement was observed for the peak cor-
responding to the bound ligand. Unfortunately, these values
decrease rapidly with time, owing to a process of deactivation
that quenches the activity of the catalyst. Attempts to block
this cyclometalation process using a smaller carbene were un-
successful under the conditions employed. We also note that
rapid H/D exchange leads to the formation of CD3OH along-
side the deuteration of the iridium hydride.
Polarization transfer of four equivalents of L9 using 1 in the
presence of p-H2 in earth’s magnetic field was also probed. The
pyrimidine ring protons were enhanced twofold. Compared
with the other ligands studied, L9 possesses the greatest steric
bulk, and so this could be the main factor for the low enhance-
ment obtained. When the ratio of L9/1 was increased to 20:1,
SABRE enhancement of the pyrimidine ring protons was not
detectable.
Hence, we can conclude that very high levels of 1H hyperpo-
larization can be achieved in 19F-containing materials under
SABRE, with the exception of L9.
2.3. 19F SABRE Hyperpolarization of F-Substituted Ligands
We have investigated the 19F hyperpolarization of the ligands
analyzed in this work by using a 500 MHz spectrometer
(11.74 T) equipped with dual capacity 1H–19F high-resolution
probe and acquired 19F hyperpolarized spectra using p/2
pulses immediately after shaking the samples in the stray field
of the magnet. As was the case for 1H, L2 provided the best re-
sponse, with enhancements of approximately 60 for the free
resonance (d 127.5 ppm) and 36 for the bound equatorial
signal (d 124.1 ppm). We note that the signal is anti-phase
when polarization is conducted in the fringe field of the
magnet, as a longitudinal two-spin order 1H–19F term is creat-
ed, which is analogous to the homonuclear 1H–1H term that is
created under in-field PHIP,[38] and so enhancements are calcu-
lated by using magnitude mode. Lower values were obtained
for the other substrates considered (see Section 4 of the Sup-
porting Information for 19F NMR spectra and full enhancement
data). Interestingly, the 19F signal of L4 is entirely in-phase,
whereas, when SABRE-SHEATH is employed, the signal be-
comes anti-phase in character. Conversely, the opposite is true
for L2. An average enhancement for L8 could not be calculated,
owing to the fast evolution of the cyclometalation process, but
both the free and the bound resonance are enhanced and dis-
play an antiphase behavior (Figure 4).
L9 resulted in a fivefold enhancement for the 19F nucleus of
the pyrimidine ring when a ratio of 4:1 L9 to 1 was employed.
Figure 3. 1H NMR single-shot SABRE hyperpolarized spectrum of L8 : aromatic
region (top) and hydride region (bottom).
Figure 4. 19F NMR single-shot spectra of L8 (7-fold excess) acquired in ther-
mal equilibrium conditions (top) and hyperpolarized under SABRE (bottom).
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This was observed as an anti-phase signal. However, no polari-
zation was observed for the other two 19F nuclei, owing to in-
sufficient J coupling to propagate polarization to these two
nuclei. SABRE-SHEATH methods did not yield any substantial
increase in the polarization observed, although they did con-
vert the signal from anti-phase to in phase (see the Supporting
Information). Despite the low enhancement observed, the T1 of
the polarized 19F resonance is 5.15 s in a measurement field of
1.4 T. This is comparable to the T1 observed for a ratio of 20:1
L9/1 at 11.74 T for the other substrates studied (see Table 2).
Although the results of the 19F hyperpolarization studies are
very promising and exhibit enhancement values high enough
to allow for high-resolution images (with the exception of L9)
to be recorded (see below), they are two orders of magnitude
lower than those obtained for 1H. This is a remarkable decrease
considering the high sensitivity of 19F, which is very close to
that of proton. In order to fully rationalize this difference, one
must take into account the relaxation and exchange rates for
the ligands analyzed, as well as the dependence of the polari-
zation transfer on the value of the magnetic field at which the
transfer takes place.
2.4. 1H and 19F Relaxation Times
We have measured and compared the 1H and 19F T1 values for
each ligand, as it is widely known that relaxation is one of the
main factors affecting the efficiency of the SABRE hyperpolari-
zation transfer process. When examining the 1H longitudinal
relaxation times of the ligands prepared in MeOD solution in
the presence of the polarization-transfer catalyst (17-fold
excess of substrate to Ir), we have found that the T1 values
range between 15 and 45 s, most of them being above 20 s
(measured at 9.4 T). The data, presented in Table 1, show that
all substrates analyzed exhibit relatively long relaxation times,
higher or comparable to those of pyridine. The lowest values
measured correspond to L7 in its protonated form, probably
owing to the presence of a hydrogen atom on the binding
center.
As shown in our previous work,[35a] addition of base and the
subsequent change in pH has a favorable effect on the T1 of
H-2 of L7, which, in this case, increases remarkably from 14.5 to
46.1 s. Smaller increases can also be noted for protons H-4 and
H-6.
When performing similar experiments to determine the cor-
responding 19F T1 values, we have found that they lie between
3.3 s (L7b) and 5.5 s (L4) when measured at 11.74 T under Boltz-
mann equilibrium conditions. This significant difference in re-
laxation rates between proton and fluorine can at least partial-
ly account for the much lower enhancements obtained for 19F
in comparison to 1H. We also note that these values are smaller
than those reported by Shchepin et al. for hyperpolarized 3-flu-
oropyridine at 9.4 T. However, a second set of T1 data collected
at 1.4 T for L4 and L2 reports that the T1 values of the
19F nuclei
are far longer than at 11.74 T by a factor of 3–5 times. This is
attributed to the relaxation process being dominated by chem-
ical shift anisotropy rather than dipolar relaxation and can,
therefore, be expected to scale with B0. In the context of
SABRE-based experiments, a similar effect has previously been
observed for 15N,[39] and more recently 19F.[14] Consequently,
these data motivated the collection of 19F hyperpolarized NMR
spectra of L2 (4 equiv relative to 1) at 1.4 T. Relative to a ther-
mal trace, this spectrum revealed that the enhancement for L2
was now 244-fold (calculated using magnitude data), an im-
provement of four times over those collected at 11.74 T. Fur-
thermore, employment of SABRE-SHEATH converted the anti-
phase signal into a 97% in-phase signal, but reduced the
signal enhancement to 93-fold. From an imaging perspective,
the appearance of the signal is important because broadened
lines can lead to partial signal cancellation.
In a further investigation, we also probed L4 in a similar fash-
ion, but also utilized our knowledge of the kinetic exchange
rates to inform our experimental protocol. Thus, the solution
was cooled to 0 8C prior to hyperpolarization in a m-magnetic
shield or at earth’s magnetic field. No change was evident for
the measurements that were polarized at earth’s magnetic
field, whereas employing SABRE-SHEATH at 0 8C yielded a nine-
fold improvement over those at room temperature. Further-
more, the 19F signal is now completely in-phase, whereas the
analogous spectrum collected following polarization transfer at
earth’s magnetic field displays anti-phase character.
The relatively long 1H longitudinal relaxation times (Table 2)
were exploited in INEPT experiments, in which the 1H polariza-
tion was transferred to 13C and to 19F nuclei, respectively. In
the case of 13C nuclei, this led to a significant increase in the
enhancement values compared to the results obtained in
Boltzmann equilibrium conditions, allowing us to record high-
quality 13C spectra in less than one second (see Section 3 of
the Supporting Information). We also note that, in the case of
L2 and L7b, the use of an INEPT sequence for the acquisition of
hyperpolarized 19F spectra led to a signal gain of approximate-
ly 230- and 100-fold, respectively, when the results obtained
Table 1. 1H longitudinal relaxation times (T1 [s]) of the individual protons
of the substrates tested, measured at 9.4 T on samples prepared using
5 mm of 1 and 17-fold excess of ligand.
Proton L2 L4 L6 L7a L7b Pyridine[a]
H-2 19.03 21.90 – 14.52 46.14 12.6
H-3 – – 22.59 - – 14.7
H-4 13.47 29.24 – 14.54 16.04 18.9
H-5 21.11 – 25.28 – – 14.7
H-6 11.56 21.90 27.09 12.73 16.91 12.6
[a] As reported by Lloyd et al.[29]
Table 2. 19F longitudinal relaxation times (T1 [s]) of the fluorine resonan-
ces of the substrates tested, measured on samples prepared using 5 mm
of 1 and 17-fold excess of ligand.
L2 L4 L6 L7a L7b
11.74 T 4.46 5.51 4.91 3.16 3.28
1.4 T 23.56 18.21 – – –
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using p-H2 are compared with the INEPT spectra acquired in
Boltzmann equilibrium conditions (see Section 4 of the Sup-
porting Information for spectra and full data).
2.5. 19F MRI Results
To assess the potential of the ligands studied in this work as
MR contrast agents for medical investigations, we have under-
taken a series of MRI experiments performed on phantoms
containing 5 mm of 1 and 100 mm of substrate dissolved in
MeOD. Following p-H2 addition, the samples were shaken in
the stray field of the magnet and, after being in the imaging
probe head, were quickly (after ca. 10 s) inserted into the spec-
trometer. One-shot 19F MR images were acquired by using a
double resonance 13C–19F 30 mm birdcage coil (19F frequency
376.5 MHz), employing a RARE acquisition protocol (see Sec-
tion 5 of the Supporting Information for full experimental
data).
SNR values have been calculated for each image by dividing
the mean signal value by the standard deviation of the noise.
The increase in SNR obtained by using SABRE was evaluated
by comparing the values obtained for the hyperpolarized
image with the SNR obtained for images acquired in Boltz-
mann equilibrium conditions (see Section 5 of the Supporting
Information). The best results were obtained when using L2,
for which the hyperpolarized results exhibited a 104-fold maxi-
mum increase in SNR and an average gain of 100-fold when
compared with the image acquired in Boltzmann equilibrium
conditions (see Section 5 of the Supporting Information for
details).
Furthermore, the MRI experiments emphasize the effect of
deprotonation on the polarization-transfer efficiency: while the
hyperpolarized images of L7a have a very low intensity and ex-
hibit no increase in SNR compared to the thermal counterpart,
the values obtained for L7b show that SABRE hyperpolarization
lead to a 75-fold SNR gain compared to the result acquired in
Boltzmann equilibrium conditions (Figure 5).
We believe that these results would be significantly im-
proved if the time taken to transfer the sample into to the
magnet for observation could be reduced (i.e. the amount of
time between polarization and detection), as a significant
amount of signal is lost during the 10 s interval (ca. 2T1) im-
posed here by our hardware limitations.
3. Conclusions
We have evaluated the capacity of a wide range of fluorinated
molecules to react with [IrCl(IMes)(COD)] (1) and H2 to success-
fully form a SABRE-active catalyst that facilitates polarization
transfer to 19F. This builds on the earlier reports of Adams et al.
and Shchepin et al.[13,14] We have found that 2-fluoropyridine
(L1) and pentafluoropyridine (L5) react weakly, if at all, with the
catalyst precursor. As both molecules possess ortho-fluorine
nuclei, there could be a possibility that steric hindrance
around the nitrogen used to ligate to the metal center of 1 is
preventing effective ligation. In the case of 4-fluoropyridine.HCl
(L3.HCl), attempts to isolate the base were unsuccessful and
this ligand was not investigated in detail. SABRE polarization-
transfer catalysts were formed by using L2, L4, L6, L7, L7, and L9
through reaction with 1 in the presence of H2; in the case of
L7 and L8, the formation of the activated catalyst was promot-
ed by deprotonating the N center of the conjugate acid using
a mild base (Cs2CO3). The performance of the new SABRE cata-
lysts was analyzed as a function of ligand loading, polarization
transfer field, temperature (L4), and pH (L7).
When comparing the 1H-hyperpolarized NMR results ob-
tained on the fluorinated compounds studied in this work with
the ones obtained using pyridine, we find that when working
at low ligand loadings (one-fold excess of substrate), the total
enhancement obtained for each molecule is considerably
lower than for pyridine. However, when moving to high ligand
loadings (17-fold excess of substrate), the performance of pyri-
dine is surpassed by L2 and L6 (with enhancements which are
3.2 and 1.2 higher), whereas the enhancements obtained for L4
and L7b become comparable to the ones of pyridine. We show
that this can be explained by considering the effect of relaxa-
tion in these fluorinated ligands, which relax slower, on aver-
age, than pyridine under the same conditions. We note that, in
the case of L7, deprotonation using Cs2CO3 leads to a remark-
able increase in T1 of the proton located between the N center
and the carboxylic group, from 14.5 to 46.1 s. Our work dem-
onstrates that, by varying the ligand loading and p-H2 concen-
tration, it is possible to dramatically exceed the previously re-
ported 1H hyperpolarization levels. 19F NMR hyperpolarized
spectra were successfully recorded for L2, L4, L6, L7a, L7b, L8,
and L9, and the average enhancements of the free fluorine res-
onance, with the exception of L8 and L9, were quantified. The
highest values were obtained for L2 and L7b (ca. 60- and 39-
fold enhancements, respectively, at 11.74 T), although we note
that the enhancement values reported by Shchepin et al.[14]
exceed the ones reported here. However, we show that, by de-
creasing the field strength at which experiments are performed
and increasing the concentration of p-H2, the enhancement of
the 19F resonance can be significantly improved.
The two orders of magnitude difference between the en-
hancements obtained for 1H and 19F can be explained by
taking into account the short longitudinal relaxation times of
19F, which range between 3 and 5 s at 11.74 T for all of the li-
gands investigated here. Although this is apparently an obsta-
cle in the way of 19F SABRE MRI applications, we show that, in
some cases, one can circumvent this situation by exploiting
Figure 5. 19F MRI SABRE hyperpolarized images of L7a (left) and L7b (right).
For comparison purposes, the same range has been used for the intensity
image data.
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the long relaxation times of the protons in INEPT polarization-
transfer experiments or by working at relatively low detection
fields.
Furthermore, hyperpolarized 2D 19F MRI images have been
recorded by using a similar polarization-transfer procedure to
that used in NMR spectroscopy experiments. When comparing
the results with their Boltzmann equilibrium counterparts, we
find that hyperpolarization facilitates an SNR gain of over one
order of magnitude for most of the substrates investigated,
particularly L2 and L7b, for which the maximum SNR gains ob-
tained were approximately 104 and 76, respectively, represent-
ing a very promising for future diagnostic MRI applications.
This work demonstrates the feasibility of using SABRE to hy-
perpolarize a wide range of 19F-substituted ligands, including
drugs included on the WHO list of essential medicines. We
present various methods, through which the polarization of 19F
nuclei can be optimized and we show, using NMR and MRI re-
sults, that some of the substrates investigated in this work ex-
hibit tremendous potential for future applications such as clini-
cal MRI investigations, molecular imaging, and in vivo pH
assessment.
Experimental Section
1H and 13C NMR measurements were recorded on a Bruker Avance
III series 400 MHz spectrometer, whereas 19F NMR measurements as
well as T1 inversion recovery and characterization experiments
were performed on a Bruker Avance III series 500 MHz system.
Samples concerning L9 and the T1 measurements at 1.4 T were col-
lected by using an Oxford Instruments Pulsar equipped with a 1H
and 19F probe. NMR samples were prepared containing 5 mm cata-
lyst precursor in 0.6 mL of [D4]MeOH. NMR measurements were
collected using either 4 or 20 equivalents of substrate to 5 mm of
iridium in 0.6 mL MeOD (leading to samples containing one- and
17-fold excesses of ligand relative to iridium, respectively). p-H2
was prepared by cooling hydrogen gas over charcoal at 20 K for all
samples, except those of L9 and measurements made at 1.4 T;
these utilized hydrogen gas over charcoal at 77 K. After adding p-
H2 at 3 bar pressure,
1H NMR spectra were recorded by using p/2
excitation pulses immediately after shaking the sample in a mag-
netic field of 65 G. A similar procedure was used for the polariza-
tion of heteronuclei. For more details about the sample prepara-
tion and experimental procedures, please see Section 1 of the Sup-
porting Information.
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in MRI and NMR Spectroscopy
Seeing is believing: The scope of hy-
perpolarization of 19F-possessing sub-
strates (including two WHO-essential
medicines) is extended by using signal
amplification by reversible exchange
(SABRE). NMR and magnetic resonance
images are presented, which underpin
the approach developed.
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